Universe Pharmaceuticals UPC
NASDAQ UPC
$4.30 -0.22 (-4.87%)
At close: Sep 30, 2026 · 4:00 PM EDT

Universe Pharmaceuticals (UPC) Current Deferred Revenue (2025 - 2026)

Updated

Universe Pharmaceuticals' Current Deferred Revenue was $42.01 billion in the quarter ended Mar 31, 2026.

Analysis

Universe Pharmaceuticals (UPC) Current Deferred Revenue (2025 - 2026) Analysis & Trends

As of Sep 30, 2025, Current Deferred Revenue at Universe Pharmaceuticals came in at $40.71 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Universe Pharmaceuticals 1.96 Mn -1,525.28 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 42.01 Bn
Sep 30, 2025 40.71 Bn
API Access

Universe Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=UPC&period=max&api_key=YOUR_API_KEY